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ABSTRACT Three model biomembrane systems, monolayers, micelles, and vesicles, have been used to study the influence of chemical
and physical variables of hapten presentation at membrane interfaces on antibody binding. Hapten recognition and binding were
monitored for the anti-fluorescein monoclonal antibody 4-4-20 generated against the hapten, fluorescein, in these membrane models as
a function of fluorescein-conjugated lipid architecture. Specific recognition and binding in this system are conveniently monitored by
quenching of fluorescein emission upon penetration of fluorescein into the antibody's active site. Lipid structure was shown to play a
large role in affecting antibody quenching. Interestingly, the observed degrees of quenching were nearly independent of the lipid
membrane model studied, but directly correlated with the chemical structure of the lipids. In all cases, the antibody recognized and
quenched most efficiently a lipid based on dioctadecylamine where fluorescein is attached to the headgroup via a long, flexible
hydrophilic spacer. Dipalmitoyl phosphatidylethanolamine containing a fluorescein headgroup demonstrated only partial binding/
quenching. Egg phosphatidylethanolamine with a fluorescein headgroup showed no susceptibility to antibody recognition, binding, or
quenching. Formation of two-dimensional protein domains upon antibody binding to the fluorescein-lipids in monolayers is also pre-
sented. Chemical and physical requirements for these antibody-hapten complexes at membrane surfaces have been discussed in terms
of molecular dynamics simulations based on recent crystallographic models for this antibody-hapten complex (Herron et al., 1989.
Proteins Struct. Funct. Genet. 5:271-280).
INTRODUCTION
Molecular-level surface recognition and binding are es-
sential features ofnormal cell membrane function. Gen-
erally, highly specific ligand-receptor interactions charac-
terize recognition and binding of solubilized molecules
by membrane-bound receptors. Moreover, antibody rec-
ognition of cell-surface antigenic determinants specific
to individual cell types or common to sets of cell types
are key components of histocompatibility and immune
responses. In addition, specific recognition of cell mem-
brane epitopes by antibodies or significant fragments of
antibodies forms the basis for new targeted drug delivery
strategies and immunoassays. At the level of the cell
D. W. Grainger's present address is Department of Chemical and
Biological Sciences, Oregon Graduate Institute of Science and
Technology, 19600 NW Von Neumann Drive, Beaverton, OR
97006-1999, USA.
C. Salesse's present address is Centre de Recherche en
Photobiophysique, Universite du Quebec a Trois-Rivieres, Trois-
Rivieres, Quebec, Canada.
Address correspondence to H. Ringsdorf.
Abbreviations used in this paper: CMC, critical micelle concentration;
CPU, central processing unit; DNP-PE, N-dinitrophenyl
phosphatidylethanolamine; DODA-(EO)4-FITC, I-N,N-
dioctadecylamidocarboxy- 1 9-(5'-fluoresceinthioureoyl)-4-carboxy-5-
oxa-2,8, 11,14,17-pentaoxa-nonadecane; DPPC, L-a-
dipalmitoylphosphatidylcholine; DPPE-FITC, L-a-N-fluorescein
thiocarbamoyl dipalmitoyl phosphatidylethanolamine; Egg PE-FITC,
egg N-fluorescein thiocarbamoyl phosphatidylethanolamine; Fab,
Fab fragment of the 4-4-20 antibody; Fv, variable region of the Fab
fragment; Fv-DODA, Fv bound to DODA-(EO)4-FITC;
Fv-DPPE, Fv bound to DPPE-FITC; Fv-fluor, Fv bound to free
fluorescein; MD, molecular dynamics simulations; MIPS, million
instructions per second; POPC, L-a-phosphatidylcholine,
3-oleoyl--y-palmitoyl; RMS, root mean squared; XRITC,
rhodamine X isothiocyanate.
membrane, therefore, selectivity and high affinity bind-
ing are critical to cell function.
Various cell membrane models have helped character-
ize recognition phenomena in lipid membranes, particu-
larly the interactions between solubilized proteins and
membrane-bound binding sites (for reviews, see Rings-
dorf et al., 1988; McConnell et al., 1986). In lipid mono-
layers, high affinity binding of antibodies to lipid-bound
haptens (Uzgiris and Kornberg, 1983; Uzgiris, 1987),
cholera toxin to ganglioside GM 1 (Reed et al., 1987;
Ribi et al., 1988), ribonucleotide reductase to nucleoli-
pids (Ribi et al., 1987), and streptavidin to biotin lipids
(Blankenburg et al., 1989; Ahlers et al., 1989) causes
these proteins to self-organize into two-dimensional
crystals at the interface. Hydrolytic action of the mem-
brane-active enzyme, phospholipase A2, has also yielded
large, curious regular-shaped protein domains in lipid
monolayers as detected by fluorescence microscopy
(Grainger et al., 1989, 1990). In all of these systems, spe-
cific binding of macromolecules to lipid biomembrane
models simulates surface recognition processes.
The fluorescein/anti-fluorescein monoclonal anti-
body system is a valuable hapten-binding pair to investi-
gate interactions of antibodies with model biomem-
branes. Initially, the anti-fluorescein system is particu-
larly useful for investigating the molecular basis of
antigenic specificity because monoclonal antibodies
with a wide range ofbinding affinities (1 05- 10 10 M-l) are
available and an array ofexperimental techniques can be
used to access information on binding affinities, kinetics,
and thermodynamics of interaction (Kranz and Voss,
1981; Kranz et al., 1982; Herron, 1984; Herron et al.,
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1986; Gibson et al., 1988). Fluorescence measurements
are sensitive to the fluorophore environment, leading to
novel information about hapten incorporation into the
antibody binding site. Recent crystallographic detail of
the Fab fragment of a particular antifluorescein idiotype
(Herron et al., 1989) has demonstrated with high resolu-
tion how the fluorescein hapten is bound into the active
pocket and the molecular-level interactions in this re-
gion. Moreover, the use of fluorescein as both the hapten
and the fluorescent probe is ideally suited for its use as a
lipid-bound antigen in model biomembrane systems due
to its relatively simple covalent addition to existing syn-
thetic and natural lipids (Petrossian et al., 1985; Struck
and Pagano, 1980; Knight and Stephens, 1989). Various
lipids containing fluorescein as a hydrophilic headgroup
are available (Petrossian et al., 1985) and its incorpora-
tion into various model biomembrane systems is rather
simple (Petrossian and Owicki, 1984) so that physico-
chemical factors governing the binding of fluorescein by
anti-fluorescein antibodies may be systematically stud-
ied. Moreover, this antibody/fluorescein-lipid system al-
lows direct quantification of the extent of specific bind-
ing in model membranes because, upon binding, the flu-
orescence of the hapten is quenched.
In this investigation, the interaction, binding, and
quenching behaviors ofa high binding-affinity antifluor-
escein antibody with fluorescein-containing lipids has
been studied as a function oflipid architecture and physi-
cal nature of the interface of three different biomem-
brane models. Fluoresceinated lipids were incorporated
into lipid monolayers, micelles, and giant vesicles. The
ability of the anti-fluorescein antibody to recognize and
quench the fluorescein antigen in these systems has been
quantitated and compared as a function of various lipid
chemistries and membrane physical structures. In addi-
tion, two-dimensional antibody domain formation as a
function of fluorescein-lipid binding in lipid monolayers
has been directly visualized in situ using fluorescence
microscopy at the air-water interface. Molecular dy-
namics simulations using the known crystal structure for
this same antibody Fab fragment interacting with lipid
monolayers are included to complement experimental
measurements. These molecular models were used to
support conceptual models for differences in antibody
recognition observed in experimental findings.
MATERIALS AND METHODS
L-a-dipalmitoylphosphatidylcholine (DPPC), L-a-phosphatidylcho-
line, f3-oleoyl-y-palmitoyl (POPC), fluorescein (sodium salt), octyl glu-
coside, emulphogene BC-720, and L-a-N-fluorescein thiocarbamoyl
dipalmitoylphophatidylethanolamine (DPPE-FITC) were purchased
from Sigma Chemical Co. (St. Louis, MO). DPPC and POPC were used
as supplied. DPPE-FITC was reconstituted in a fresh chloroform solu-
tion by removing the solvent (chloroform-methanol) from the sup-
plier's solution, weighing the dry product and redissolving the solid in a
known amount of chloroform. I-N,N-dioctadecylamidocarboxy-19-
(5'-fluoresceinthioureoyl-4-carboxy-5-oxa-2,8, 11,14,1 7-pentaoxa-
nonadecane (DODA-(EO)4-FITC) was synthesized and certified pure
1 2 3
SCHEME 1 Structure offluoresceinated lipids: (1) DODA-(EO)4-FITC;
(2) Egg PE-FITC; and (3) DPPE-FITC.
by NMR and fast atomic bombardment mass spectrometry as de-
scribed (unpublished results). Egg phosphatidylethanolamine contain-
ing fluorescein at the head group (Egg PE-FITC) derived from hydroly-
sis of egg lecithin was obtained from Avanti Polar Lipids and used as
supplied. All lipids were analyzed first by thin layer chromatography
and then by monolayer isothermal measurements at the air-water in-
terface (Ahlers et al., 1992). Moreover, gas chromatographic analysis of
DPPE-FITC showed a fatty acid chain composition for this lipid of
96.6% 16:0 (palmitoyl), 2.4% 18:0 (stearoyl), 0.4% 18:1 (oleoyl), and
0.6% unidentified fatty acid components. The same analysis of Egg
PE-FITC yielded fatty acids of the following distribution: 34.3% 16:0
(palmitoyl), 2.1% 16:1, 10.3% 18:0, 30.6% 18:1 (oleoyl), 18.1% 18:2,
0.4% 20:3w6, 2.5% 20:4w6, 0.1% 22:4w6, 0.6% 22:5w6, 0.4% 22:6w3,
and 0.6% unidentified.
A 50 mM phosphate buffer (pH 8.0) and a 0.5 M sorbitol solution
were prepared from high purity reagents (Merck, Darmstadt, FRG)
using acid-cleaned flasks. All water was distilled three times on glass
and then purified by a Milli-Q water purification system (Millipore). Its
resistivity was greater than 18 MQ-cm. Chemical structures of all fluor-
esceinated-lipids used in this study are shown in scheme I. The Egg
PE-FITC structure is representative ofthe major mixed fatty acid phos-
pholipid component (palmitoyl and oleoyl) in this compound.
A murine monoclonal antibody directed specifically against fluores-
cein (clone 4-4-20, anti-fluorescein antibody) was obtained from Pro-
fessor Monte Reichert (Duke University) as a gift from Professor E. W.
Voss, Jr. (Department of Biochemistry, University of Illinois-Cham-
paign-Urbana). This clone is an IgG2,(K) antibody that binds fluores-
cein with a binding constant of 3.4 x 10'0 M' in aqueous solution
(Bates et al., 1985) and shows no cross reactivity with rhodamine
(Kranz and Voss, 198 1; Voss et al., 1976). A portion ofthis monoclonal
antibody was labeled with rhodamine X isothiocyanate (XRITC; Mo-
lecular Probes) using standard methods (Nargessi and Smith, 1986)
and purified on a Pharmacia PD-I 0 (Sephadex G-50 M) column equili-
brated with Millipore water. After lyophilization, the antibody product
was weighed, dissolved into 50mM phosphate buffer, pH 8.0 in Eppen-
dorf vials, and frozen until used. The activity ofboth labeled and unla-
beled antibodies was controlled by measuring the extent of fluores-
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cence quenching of pure fluorescein in solution (phosphate buffer, pH
8.0) by a modification of the method of Petrossian and Owicki (1984).
Both antibodies showed identical activities, indicating that its binding
is unaffected by the labeling process.
Moreover, Scatchard analyses (data not shown) of antibody-fluores-
cein titrations (based on the method of Herron, 1984) yielded an anti-
body valency of -2 with a binding constant of 1.9 x 109 at room
temperature (23°C), which compares quite well with previously pub-
lished values (Pertrossian and Owicki, 1984; Herron, 1984). This data
was compared with antibody concentration data calculated from the
antibody extinction coefficient from solution UV measurements. This
apparent antibody concentration (8.88 x 10-' M) was compared with
that concentration determined from Scatchard analysis assuming a va-
lency of2 (8.5 x 10 `M). These two values compare very well. The two
approaches to assessing antibody purity and binding indicate that the
antibody preparation is fully active and unaffected by labeling and
subsequent handling.
Antibody recognition, binding, and
fluorescence quenching in micelles
Micellar solutions of all fluorescein-lipids as well as pure fluorescein
were typically prepared as follows: a 3.5 x 10- M solution of fluores-
cein-lipid was prepared by weighing the lipid with an electrobalance
and solubilizing it in chloroform. Subsequently, 200 Al of this solution
were withdrawn and evaporated in a 250 ml volumetric flask. This lipid
was then solubilized in a 1.2 x 10-' M solution of emulphogene in 50
mM phosphate buffer, pH 8.0, i.e., slightly above the cmc ofemulpho-
gene (8.7 x 10-5 M). Then, 200 Al ofthis solution were withdrawn and
further diluted to 100 ml with the same emulphogene solution. Two ml
of this solution, containing typically 1 x 10- 12 mol of fluorescein-lipid,
were then used for the fluorescence measurements. In the case of octyl
glucoside, because of its much higher cmc (2.3 x 10-2 M), dilutions
were performed in smaller volumes and the initial lipid concentration
in chloroform was ten times more dilute. In the case of pure fluores-
cein, the weighed sample was solubilized and further diluted directly in
the micellar (i.e., emulphogene or octyl glucoside) solution in order to
reach the same final concentration as for the fluorescein-lipids. The
binding constant obtained for pure fluorescein in detergent micelles is
very similar to the one measured in buffer (see above).
Quenching measurements were performed by using a modification
of the method of Herron (1984). Typically, 1 x 10-1' mol (50 ,l) anti-
fluorescein antibody was added to a 3 ml thermostatted fluorescence
cuvette. Then, a quick addition of the 2 ml micellar fluorescein-lipid
solution was made and the fluorescence was measured immediately.
Stanton et al. ( 1984) have show that the excitation and emission max-
ima of fluorescein-lipids vary as a function of lipid hapten environ-
ment. Maximum differences between excitation maxima in several dif-
ferent lipid environments (e.g., DMPC/cholesterol vs. DPhPC) were 10
nm. This difference of 10 nm was witnessed also in the emission spec-
tra. We have carefully determined the excitation and emission spectra
for our haptenated lipids in micelles and compared it with free fluores-
cein under the same conditions. Our results show very small differences
(2-3 nm shifts) in both excitation and emission spectra between the
haptenated lipids. The fluorescein-lipids (and fluorescein) were thus all
excited at 492 nm and their fluorescence was recorded at 522 nm. The
fluorescence spectrometer used was a Spex Fluorolog equipped with a
double monochromator both at the excitation and emission beams.
The slits were positioned at 1.0 mm and the integration time was set at
1 s. Measurements were performed at 20°C.
Antibody recognition, binding,
fluorescence quenching, and
two-dimensional protein domain
formation in mixed lipid monolayers
Surface pressure-area measurements
Specific binding of anti-fluorescein antibody to DODA-(EO)4-FITC in
mixed monolayers and its nonspecific adsorption on POPC mono-
layers was evaluated by measuring the expansion ofmonolayer molecu-
lar area at constant surface pressure. The monolayer trough used has
been described previously (Albrecht, 1983). Monolayers ofpure POPC
or POPC containing 10 mol% DODA-(EO)4-FITC were prepared by
spreading 100 ,l of a 10-4 M lipid solution in chloroform at the
air-water interface at 20°C on 50 mM phosphate buffer, pH 8.0. The
film was then compressed to 16 mN/m and after 40 min equilibration
time, the anti-fluorescein antibody was injected in the subphase be-
neath the monolayer (175 ,g protein in 5 ml; subphase volume, 100
ml) and the increase in molecular area was then monitored.
Fluorescence microscopy measurements
The fluorescence microscope and the miniaturized film balance used
have been described previously (Meller, 1988, 1989). For the quench-
ing measurements, a computer-controlled high sensitivity photometer
(Microscope System Processor MSP-20, Zeiss) was connected directly
to the microscope photometer head via a port between the camera and
the reflecting stage of the fluorescence microscope. The photometer is
also equipped with a computer-controlled shutter which was set to
open for 150 ms every 30 s. The POPC lipid monolayer containing 1
mol% of either DODA-(EO)4-FITC, DPPE-FITC or Egg PE-FITC was
prepared by spreading 30,1 of a 4 x 10' M solution at the air-water
interface. Solvent was allowed to evaporate and the monolayer was
compressed until the desired surface pressure was reached. The 100%
fluorescence intensity value was then recorded by the photometer and
the anti-fluorescein antibody was injected into the subphase (15 jig in 1
ml; subphase volume, <2.5 ml) beneath the monolayer while an equiva-
lent volume of subphase was simultaneously withdrawn from behind
the compression barrier. Measurement of the decrease of monolayer
fluorescence as a function of time was then immediately initiated. Ad-
ditionally, in similar experiments, XRITC-labeled anti-fluorescein an-
tibody was used to directly observe the formation of two-dimensional
protein domains in fluorescein-lipid monolayers. Dual labeling
(XRITC-antibody and fluorescein-lipids) allowed easy differentiation
of monolayer quenching from protein domain formation. Zeiss filters
487709 and 487714 were used to visualize the fluorescein-lipids and
the XRITC-labeled antibody, respectively.
As discussed above, Stanton et al. (1984) have reported that the exci-
tation and emission maxima of fluorescein-lipids vary as a function of
lipid hapten environment. However, in the present fluorescence micros-
copy measurements, the 487709 interferential filter used allows fluores-
cein excitation between 450-490 nm. The dichroic mirror used in the
filter assembly has a cut-off at 510 nm and the long pass emission filter
allows measurement of fluorescence above 520 nm. Moreover, the
HBO 100 mercury lamp on the microscope has a very flat light intensity
profile in this excitation range (no lines between 450-530 nm); excita-
tion intensity remains relatively constant across the spectrum ofexcita-
tion for the various lipid hapten systems, regardless of the lipid struc-
ture, excitation maximum or environment. Moreover, the hapten lip-
ids were consistently highly diluted (1 mol%) in the same POPC lipid
environment. Possible emission shifts from environmental effects are
thus accounted for by the long pass filter which detects all emission
above 520 nm collectively. Red shifts in the excitation and emission
bands for each hapten in the POPC matrix as a function oflocal hapten
environment should be accounted for given the band widths of the
filter system and the nature ofthe broad spectrum detection apparatus.
Antibody recognition, binding, and
fluorescence quenching
in lipid vesicle systems
Lipid mixtures containing 99 mol% DPPC and 1 mol% ofeither DPPE-
FITC, DODA-(EO)4-FITC, or Egg PE-FITC were prepared by dissolv-
ing DPPC in chloroform and adding the proper amount ofeach respec-
tive fluorescein-lipid in chloroform solution. Giant lipid vesicles were
prepared by a procedure similar to that reported by Reeves and Dow-
ben (1969). A volume of 5 ,al of each mixture as well as a pure DPPC
solution as control were deposited onto glass microscope coverslips as
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small droplets. The drops were allowed to air dry and were subse-
quently placed in vacuum to remove residual chloroform, forming
small, circular lipid films -1 mm in diameter on the coverglass. The
glass coverslips were then installed in a specially designed thermostated
flow chamber (Decher et al., 1989, 1990) for observation using an in-
verted fluorescence microscope. The flow chamber was slowly filled
with 0.5 M sorbitol solution in Millipore water and immediately heated
to 45°C (above the phase transition of DPPC) to promote swelling of
the lipid films into giant vesicles in the flow chamber (Servuss, 1988;
Reeves and Dowben, 1969; Lasic, 1988a, b). After swelling to giant
vesicles (10-100 ,um diameter), the sorbitol medium in the flow
chamber was exchanged slowly (0.3 ml/min flow rate) with a 50 mM
phosphate buffer solution (pH 8.0) at the same temperature using a
microsyringe pump. After 10 ml of buffer exchange (40 times flow
chamber volume), the temperature was cooled to 37°C and allowed to
equilibrate for 30 min.
XRITC-labeled anti-fluorescein antibody in the same phosphate
buffer (0.1 ml, 35 ,g, 2.0 x 10-9 mol) was injected slowly into the flow
chamber using a microsyringe pump (flow rate 0.3 ml/min). This
amount of antibody represents approximately a three-molar excess of
antibody to total lipid deposited as film on the coverglass. However,
such an estimation is not so valuable when considering that only a
small part ofthe total lipid present on the glass swells into vesicles, and
that only a fraction of the total lipid present as vesicles resides in the
outer vesicle leaflet, exposed to antibody in the full, exterior aqueous
phase. The anti-fluorescein antibody was allowed to incubate with the
swollen lipid film for 30 min and excess, unbound antibody was subse-
quently rinsed out ofthe chamber with 15 ml ofphosphate buffer (flow
rate 0.3 ml/min).
The recognition and binding reactions of the anti-fluorescein anti-
body against the fluorescein hapten present as the various fluorescein-
lipids in the giant vesicles was directly observed in the flow chamber
using fluorescence microscopy. Giant vesicles are large enough to be
easily distinguished with such methods (Ringsdorf et al., 1988; Decher
et al., 1989, 1990). A Zeiss inverse IM35 microscope with phase-con-
trast and epifluorescence capabilities (40 times objective, working dis-
tance = 0.7 mm) has been used in combination with a reflex camera to
obtain photographs of antibody binding to giant vesicles. Three types
of results were sought: phase-contrast photographs of giant vesicles,
photographs of the excited fluorescein-conjugated lipids in these same
vesicles, and photographs of the XRITC-labeled anti-fluorescein anti-
body recognition and binding to these same vesicles. By switching be-
tween these various optical conditions, antibody binding to giant vesi-
cles could be directly observed and distinguished between the various
fluorescent lipid vesicles and DPPC controls. Ektachrome slide film
(400 ASA) was used. I-min exposure times were used for all XRITC-la-
beled anti-fluorescein antibody photographs, 30-s exposure times were
used for all fluorescein-conjugated lipid photographs, and an auto-
matic setting was used for the phase-contrast photographs. Slides were
developed using standard techniques with identical developing condi-
tions for all photographs. Prints were taken from the slides using con-
ventional techniques. In the case ofthe XRITC-labeled systems where
a relative quantification ofantibody binding was sought by comparing
fluorescence intensities, slides having the brightest XRITC fluores-
cence (from anti-fluorescein antibody binding to DODA-(EO)4-FITC
lipid vesicles) were used as the exposure standard, and all other XRITC
prints were then made under these identical exposure conditions. In
this way, an internally consistent method to relate XRITC intensity in
each case to quantify relative antibody recognition was achieved. Each
lipid vesicle experiment was repeated at least twice with the same re-
sults.
Molecular dynamics simulations
of antibody interaction with lipid
monolayers
Molecular simulations of the binding of fluoresceinated lipids by the
4-4-20 antibody were also performed to compare with experimental
results. Complete reviews ofthe theory and methods ofmolecular simu-
lations of biological molecules have been published (Hagler, 1985;
McCammon and Harvey, 1987; Brooks et al., 1988). The computer
model was constructed from three components: (a) the crystal struc-
ture of the variable (Fv) fragment of the 4-4-20 antibody Fab binding
domain (Herron et al., 1989), (b) a phosphatidylcholine monolayer
matrix, and (c) one of the three types of fluoresceinated lipids used in
the experimental section (DODA-(EO)4-FITC, DPPE-FITC, and Egg
PE-FITC). Because of the inclusion of a large monolayer component
and a limitation on computation time, only the variable region includ-
ing the binding site ofthe Fab fragment (Fv) was included in the simula-
tions. Total numbers ofatoms numbered 1674 for the light chain ofthe
Fv and 1834 for the heavy chain ofthe Fv. Three sets of48-picosecond
molecular dynamics simulations (MD) were run: (a) the 4-4-20 Fv
bound with free fluorescein (Fv-fluor), (b) Fv bound to DODA-(EO)4-
FITC (Fv-DODA), and (c) Fv bound to DPPE-FITC (Fv-DPPE). In the
Fv-fluor MD, energy minization ofthe x-ray crystal structure ofbound
fluorescein was performed for 100 cycles before the start of the actual
MD run. The temperature of the MD was raised from 1 to 300 K in
increments of 30 K/100 steps and then maintained at 300 K for the
remainder ofthe MD run. Each step size was 1 fs. Coordinate sets ofthe
protein-ligand system were saved every 0.1 ps or every 100 steps. The
dielectric constant for the electrostatic calculations was set at 78. DIS-
COVER program was used in the energy minimization and MD.' Its
performance and forcefield parameters have been published (Dauber-
Osguthorpe et al., 1988; Ornstein, 1990).
In the Fv-DODA and Fv-DPPE MDs, a monolayer ofphosphatidyl-
choline lipid structures was constructed in a planar array to simulate Fv
fragments bound to the water-monolayer interface. Each phospholipid
molecule was abbreviated to a C2-phosphatidylcholine form (no acyl
chains) and the alkyl region of the monolayer was held fixed through-
out the duration ofthe MD runs. For this reason, the results for DPPE-
FITC are identical to those ofEgg PE-FITC. 77 ofthese molecules were
constructed and placed in a geometrical spacing similar to that known
for the crystal structure ofDMPC (Pearson and Pascher, 1979; Hauser
et al., 1981). Energy minimization was then performed to remove steric
overlaps. No periodic boundary conditions were used. A phospholipid
molecule in the center of the monolayer array was then removed and
replaced with the energy minimized fluoresceinated lipid of interest
(DODA-(EO)4-FITC or DPPE-FITC). The extended form of the fluo-
rescein-lipid was then bound to the Fv fragment by direct superposition
of fluorescein groups using the energy minimized crystal structure of
Fv containing free fluorescein. Finally, the entire Fv-lipid monolayer
molecular system (7196 atoms for Fv-DODA, 7161 atoms for Fv-
DPPE) was subjected to molecular dynamic simulations under the
same conditions as described for Fv-fluor.
Fv orientation with respect to the monolayer could not be made
identical for both Fv-DODA and Fv-DPPE models. In the initial place-
ment of the protein on the monolayer, the shorter spacer length be-
tween the fluorescein group on DPPE-FITC and the monolayer inter-
face created a strong steric problem with the result that the Fv heavy
chain resided closer to the monolayer initially in the Fv-DPPE case
than in the Fv-DODA case.
To test the forcefield's ability to maintain the planarity ofthe fluores-
cein ring components, the RMS deviation ofthe xanthenone three-ring
atoms from the plane was calculated with a subroutine from an x-ray
structure refinement program, PROLSQ (Hendrickson and Konnert,
1981). The ring was placed on the x-y plane and the average displace-
ment of the ring atoms in the z-direction was calculated. The vector
perpendicular to the plane ofthe ring can also be calculated. The direc-
tional vectors of each of the two halves of the xanthenone were calcu-
lated and the angle between them is also used to measure the planarity
of the ring. The directional vectors of the whole xanthenone and the
phenyl ring were also used to calculate the angular relationship be-
'DISCOVER is a molecular simulation program from Biosym Tech-
nologies, San Diego, CA 92121.
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FIGURE 1 Assigned geometric relationships between the model hap-
ten, fluorescein, and three 4-4-20 antifluorescein antibody binding site
residues (ARG 39L, TRP 33H, and TYR 37L) in molecular dynamics
calculations: d = distance between geometric centers ofbound fluores-
cein and ARG39L; ( = angle formed by TRP33H, bound fluorescein,
and TYR37L.
tween the two ring (xanthoyl vs. phenylcarboxy) components offluores-
cein.
Also calculated were the distance, energetic, and angular relation-
ships between bound fluorescein and certain amino acid residues in the
4-4-20 binding site (assigned geometry shown in Fig. 1). The geometri-
cal centers for the ring portions ofTYR 37L, TRP 33H, bound fluores-
cein, and the three atoms at the tip of the ARG 39L side chain were
determined, along with the calculated distances and angles.
Fv quaternary structural changes resulting from the binding ofdiffer-
ent fluorescein conjugates were also calculated by comparing the posi-
tions of the antibody variable domain chains (Vl1&, and Vh<,,) relative
to each other over time. This VL-VH plane angle is defined in Fig. 2
showing the angle between the Fv light and heavy chain components.
The 39 C-a atoms of the conserved /3-sheet residues in each of VL and
VH domains were used to define a plane running through each domain,
and then the angle between the two planes was calculated over the
MD run.
RMS calculations for changes in the Ca Fv skeleton and deviation
from the x-ray coordinates for certain amino acid binding site residues
were also made as a function ofMD run time. The changes with each
hapten were referenced to an Fv-fluor structure that had been energy-
minimized to less than 0.01 kcal/mol energy derivative. The final Fv-
hapten complexes were superimposed upon the reference Fv-fluor
structure to calculate the RMS deviations in the Ca backbone. Differ-
ences between the coordinate averages over the MD time periods were
used to compare the structural changes of Fv induced with the various
haptens at the monolayer interface.
conseved f-sheet regions
plane angle between conserd regions
fluorescein
FIGURE 2 Angle defined by planes containing Ca heavy and light
chain ,3-sheet regions in the antibody variable domains (VL and VH) at
the terminus of each 4-4-20 Fab fragment. This angle is used to moni-
tor changes in binding site quaternary structure upon hapten binding.
Computation of the 48-ps MD runs took 424 CPiJ hours on one of
two processors of the Silicon Graphics 4D/220S computer rated at 20
MIPS (million instructions per second) for Fv-DODA, 448 CPU hours
for Fv-DPPE and 196 CPU hours for Fv-fluor.
RESULTS
Recognition, binding, and
fluorescence quenching of
fluorescein-containing lipids in
micelles
Fig. 3 shows the percentage offluorescence quenching as
a function of time for different fluorescein-containing
lipids in micelles as compared to pure fluorescein.
The kinetics observed with pure fluorescein is qualita-
tively faster than those obtained with the fluorescein-
lipids. Moreover, pure fluorescein, DODA-(EO)4-FITC,
DPPE-FHTC, and Egg PE-FITC show >90, 75, 55,
and 15% fluorescence quenching in emulphogene, re-
spectively. However, in octyl glucoside, these molecules
100%
Egg PE-FITC
5
cr
DPPE-FITC
DODA-(EO)4-FITC
0 330 660
Time (sec.)
FIGURE 3 Extent of fluorescence quenching of micellar solutions of
1 X 10-12 M fluorescein-lipid (Egg PE-FITC, DPPE-FITC, or DODA-
(EO)4-FITC) or fluorescein by the addition of 1 X 10-" M anti-fluore-
scein antibody as a function of time in 50 mM phosphate buffer, pH
8.0, containing 1.2 x 10-4 M emulphogene at 20°C.
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Injection of the pids by the antibody is observed in monolayers as in the
1.0 Anti-Fluorescein Antibody case of micelles. Indeed, the quenching varies from
70% for DODA-(EO)4-FITC, to -50% for DPPE-
A 0.8 - A FITC, and to -10% for Egg PE-FITC at 30 mN/m.
B> AK f Larger amounts of protein did not lead to any change in
0.6 these values. These absolute values are also very similar
A to those obtained in the fluorescence quenching experi-
[nm2] 0.4 ments in emulphogene micelles (see Fig. 3). Measure-
ments have also been performed at 5 and 12 mN/m for
0.2 DODA-(EO)4-FITC only (Fig. 6). In these cases, the fluo-
rescence quenching obtained is very similar to that at 30
._________________________ _ . . .mN/m except that the curves contain many more fluctu-
I ' ' ' ' ations where, during several minutes, no fluorescence40 80 120 160 200 could be detected. Observation of these films with video
t [min] > microscopy after the quenching experiments showed the
presence of large, round black aggregates surrounded by
FIGURE 4 Specific binding of anti-fluorescein antibody to a mixed a homogeneous fluorescent film at surface pressures of 5
monolayer containing 10 mol% DODA-(EO)4-FITC in 90 mol% POPC and 12 mN/m (Fig. 7). Measurements with the XRITC-
(A), and nonspecific adsorption of the antibody on pure POPC mono- labeled antibody show that these black domains ob-
layer (B). The interrupted line indicates a constant surface pressure
regime of 16 mN/m in the absence ofantibody. Subphase is phosphate erved wt the fluorescein filtere fur s wnbuffer (50 mM, pH 8.0, 20°C). Spreading solvent: CHC13. excited by the sulforhodamine filter (Fig. 7). This indi-
cates directly that the dark aggregates are large multi-
molecular clusters of XRITC-labeled antibodies bound
show a significantly lower fluorescence quenching than to quenched fluorescein-lipids at the monolayer inter-
that in emulphogene. Indeed, pure fluorescein, DODA- face. No domains of any kind were observed without
(EO)4-FITC, DPPE-FITC, and Egg PE-FITC showed, re-
spectively, 75, 55, 30, and 12% quenching (results not
shown). This difference in behavior may be attributed to
the much higher (250 fold) octyl glucoside:fluorescein
molecule ratio (5 x I07: 1) compared with that in emul-
phogene (2 x 105: 1). In both detergents, however, the
same fluorescence quenching trend is observed for all
molecules: it follows a scheme where pure fluorescein >
DODA-(EO)4-FITC > DPPE-FITC > Egg PE-FITC.
Noteworthy is that the results remained the same when
twice the amount of antibody was used.
Recognition, binding, and
fluorescence quenching
of fluorescein-containing lipids
in monolayers
Fig. 4 shows that, upon injection ofthe antibody beneath
the POPC film containing 10 mol% of DODA-(EO)4-
FITC at a constant pressure of 16 mN/m, the monolayer
undergoes a large expansion whereas the pure POPC
film remains nearly unchanged. In fact, the DODA-
(EO)4-FITC/POPC monolayer molecular area was ex-
panded by 0.2 nm2 (20 A2/molecule) (Fig. 4). The spe-
cific binding between the anti-fluorescein antibody and
DODA-(EO)4-FITC can thus easily be distinguished
from nonspecific adsorption even ifthe molar amount of
this fluorescein-lipid in the POPC film is relatively small.
Nonspecific adsorption of the antibody is thus very
small. Very low nonspecific adsorption has also been ob-
served in giant vesicles made of DPPC (Fig. 8 L).
Fig. 5 shows that a very similar trend for the fluores-
cence quenching behavior of the different fluorescein-li-
X
(n
a1)
a
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-
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C.)
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L-
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0 20 40 60 80 100
Time (min.)
FIGURE 5 Extent of fluorescence quenching of mixed monolayers
containing 1 mol% DODA-(EO)4-FITC, DPPE-FITC, or Egg PE-FITC
in 99 mol% POPC at 30 mN/m by the anti-fluorescein antibody. Sub-
phase is phosphate buffer (50 mM, pH 8.0, 20°C). Spreading solvent:
CHC13.
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FIGURE 6 Extent offluorescence quenchini
mol% DODA-(EO)4-FITC in 99 mol% POP
sures of 5, 12, and 30 mN/m by the anti-fl
conditions as in Fig. 5.
antibody additions; phase separatio
offluorescent lipid is not observed M
ent (data not shown). Moreover,
domains were not observed at sui
mN/m (figure not shown), explain
smooth curve observed at this surf
Binding ofboth Fab fragments simultaneously to fluores-
cein-lipids may not be necessary to form two-dimen-
sional protein domains, although the exact binding stoi-
chiometry at the air-water interface is difficult to ascer-
tain. Measurements at lower surface pressures (5 and 12
mN/m) were not performed with DPPE-FITC. How-
ever, a similar behavior could be expected for this lipid
because the antibody readily binds and quenches its fluo-
rescence although to a lesser extent than DODA-(EO)4-
FITC.
Recognition and binding
12mN_M Lipid bilayers, such as those present in vesicle systems,1 2mN/m present a different aggregated lipid state than either the
monolayer or micellar systems. Lipid motion and espe-
cially exchange (leaflet flip-flop or intervesicularly) is not
as dynamic as in detergent micellar systems, and vesicles
PD go obviously maintain an element of curvature not found
in the monolayer system. Moreover, quantitation offluo-
rescein hapten recognition and quenching is compli-
cated by bilayer leaflets: the outer leaflet exposed to ex-
tra-vesicular aqueous medium is accessible to the anti-
body, whereas the inner leaflet, exposed only to the
60 80 100 captured aqueous volume inside each vesicle is not.Quenching offluorescence occurs, therefore, only on the
outer leaflet, and can approach a value of -65% (Petros-
sian and Owicki, 1984). Given a relatively low radius of
3OmN/m curvature for giant vesicles and, therefore, a fairly homo-
geneous distribution of fluoresceinated lipids between
both the inner and outer leaflets, quenching of fluores-
cein-lipids on the outer membrane leaflet cannot be vi-
sually distinguished from fluorescence emission from
the unquenched inner leaflet using direct fluorescence
observation of giant vesicles in a flow cell as described.
To detect antibody recognition, therefore, the XRITC-
labeled antibody was used for binding studies. Examina-
tion of the field alternating between a fluorescein filter
and a sulforhodamine filter could then distinguish anti-
60 80 100 body's recognition and binding to the various hapten-
ated vesicles.
mIn.) Fig. 8 shows photographic evidence of antibody bind-
ing and recognition in giant lipid vesicles swollen from
g ofmixed monolayers of 1 lipid films in a flow chamber. The first column ofphotos
IC at constant surface pres- (Fig. 8, A, D, G, J) are phase-contrast views of swollen,
uorescein antibody. Other *giant vesicles in the flow chamber for each lipid mixture
(see figure legend). The second column of photographs
(Fig. 8, B, E, H, K) shows the same fields excited with a
mercury vapor lamp and a conventional fluorescein
)n and self-quenching dichroic filter system. Vesicles are seen to fluoresce
rithout antibody pres- bright green with homogeneous intensity (nonvesicular-
these antibody/lipid ized solid lipid film is also seen to fluoresce under or next
rface pressures of 30 to some vesicles). Vesicles from DPPC as control have
iing the origin of the no intrinsic fluorescence, and the field appears homoge-
face pressure (Fig. 5). neously dark (Fig. 8 K). The third column of photo-
Ahese l nioyRcgiini
20 40 60 80 100 of fluorescein-containing lipids
in giant vesicles
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FIGURE 7 Mechanism postulated for formation oftwo dimensional protein domains at the lipid-water interface: (A) Injection of XRITC-labeled
antibody beneath a monolayer of 1 mol% DODA-(EO)4-FITC in 99 mol% POPC at 12 mN/m and 20°C. (B) Binding of the anti-fluorescein
monoclonal antibody to the fluorescein-lipids and quenching of the hapten fluorescence. (C) By diffusion in the plane of the monolayer, the
anti-fluorescein antibody/DODA-(EO)4-FITC complex forms two-dimensional protein domains as observed by fluorescence microscopy of the
monolayer interface. Scale bar is 20 Aim. The micrograph on the left-hand side is taken using a fluorescein filter (monolayer signal ofthe quenched,
bound fluorescein-lipids within the fluorescent DODA-(EO)4-FITC (unbound)/POPC mixture); the one on the right-hand side using a sulforhoda-
mine filter (XRITC-labeled antibody signal).
graphs (Fig. 8 C, F, I, L) shows the identical set of fields
again, viewed under the sulforhodamine dichroic filter.
Vesicles are seen to be covered to varying degrees with
XRITC-labeled antibody, indicating different degrees of
hapten recognition with each lipid system. Significantly,
the relative degrees of antibody recognition in this vesi-
cle system agree very well qualitatively with the above
mentioned quantitative binding assessments of the anti-
body against monolayer and micellar systems. Vesicles
containing the DODA-(EO)4-FITC lipid (Fig. 8 C) are
shown to bind the most to XRITC-labeled antibody
(greatest fluorescence intensity), just as witnessed in
monolayers and micelles. Vesicles ofDPPE-FITC (Fig. 8
F) show intermediate fluorescence intensity (that is, less
XRITC-labeled antibody is bound on these vesicles than
on DODA-(EO)4-FITC containing vesicles, but obvi-
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ously more than either DPPC control or Egg PE-FITC
vesicles) (Fig. 8, L, I). Fig. 8, (photographs I and L)
shows that very little anti-fluorescein antibody is bound
to vesicles containing Egg PE-FITC or DPPC, respec-
tively, indicating that the fluorescein hapten is not recog-
nized in the Egg PE-FITC system, and that little nonspe-
cific binding of antibody occurs in agreement with the
pure POPC monolayer measurement (Fig. 4). These re-
sults agree both in qualitative and relative quantitative
terms with results for antibody recognition in monolayer
and micellar lipid systems. However, different from the
fluorescence microscopy observations (Fig. 7), any do-
main formation or patching present is neither readily
observable nor distinguishable in giant vesicles but has
been shown in a similar system using the identical experi-
mental set-up (Decher et al., 1990).
Molecular dynamics of antibody
bound to lipid monolayers
The molecular dynamics simulations assume that com-
plete binding has occurred between Fv and fluorescein
hapten at the start of the MD run. Based on the initial
coordinates of binding in the binding site, fluorescein
and Fv structures are allowed to relax within the con-
straints of the forcefield approximations. Data drawn
from these simulations include: (a) distance-time, angle-
time and energy-time dependencies between amino acid
residues in the binding pocket and the fluorescein hap-
ten (interactive changes in fluorescein binding), (b) cal-
culation ofthe dynamic ring planarity of fluorescein and
changes in the intramolecular angle defined by the plane
of fluorescein's xanthenone ring and the plane of its
phenylcarboxy ring over time, and (c) quaternary struc-
tural changes between heavy and light chains in the anti-
body variable domain as well as specific amino acids
within the binding site that are indicative of conforma-
tional changes (entropic effects) of hapten binding.
Calculations for the planarity of fluorescein were in-
tended as one validation of the forcefield model em-
ployed in these computations. If the forcefield parame-
ters are valid, the structural integrity of fluorescein (i.e.,
the planar configuration of the fluorescein xanthenone)
should be maintained. Indeed, the 48 ps study (data not
shown) indicates an angle formed by the two perpendicu-
lar vectors of each xanthenone half ring of 174 ± 4
degrees (nearly coplanar) with an RMS deviation of
0.112 ± 0.044 A. The angle formed by the plane of the
xanthenone and the phenylcarboxy ring of fluorescein is
relatively constant, fluctuating little in all cases of free
fluorescein and fluorescein lipid-antibody binding (83 +
6 degrees facing away from the active site).
Crystallography of the Fv-fluorescein complex shows
that the binding pocket is long and narrow (there is a
cleft between the Fv light and heavy chains [Herron et
al., 1989]). In binding fluorescein, a light chain arginine
residue deep in the binding pocket (ARG39L) as well as
aromatic amino acids (TYR 37L, TRP 33H) are pre-
sumed to interact strongly in this low dielectric medium
with the xanthoyl ring of fluorescein. ARG39L has been
implicated in quenching by forming an ion pair while
ring stacking with aromatic amino acids might also be
significant to quenching efficiencies (see Discussion for
further details). Thus, the distance-, angular-, and en-
ergy-time relationships ofthese amino acid residues with
fluorescein have been calculated over the duration ofthe
48 ps MD run. All data represent the same phenomena
and have similar features yielding the same conclusions.
Fig. 9 shows a comparison of the electrostatic energies
versus time between fluorescein and ARG39L. The ab-
solute magnitude of the energy values can be adjusted
arbitrarily by assigning dielectric constants, so only rela-
tive comparisons are significant. All atoms of fluorescein
and ARG39L have been used in this calculation and
ideally, there should be a linear relationship between dis-
tance and electrostatic energy (which is indeed appar-
ent). For all three simulations (free fluorescein, DPPE-
FITC, DODA-(EO)4-FITC), the mean distances (indi-
cated as "d" in Fig. 1, data not shown) and energy values
(Fig. 9) show the same patterns, but the amplitude of
fluctuation is what distinguishes between them. DPPE-
FITC shows increasingly highly damped behavior, partic-
ularly in the last third of the 48 ps MD run, indicating
hindered motions within the binding site compared to
the other cases.
Fig. 10 plots the Fv quaternary structural changes with
respect to the variable light and heavy chains resulting
from fluorescein binding. The absolute changes in the
quaternary structures during the simulation are in-
fluenced by the ligand binding and assigned dielectric
conditions; only relative differences are significant for
comparison. Free fluorescein binding causes the VL- VH
plane angle to open significantly, inducing the Fv frag-
ment to change its conformation. For the lipid-conju-
gated fluoresceins, the angle fluctuates substantially but
does not open. Less structural changes are seen, indicat-
ing again that these lipid haptens rigidify the binding site
formed by the light and heavy chains when fully bound.
DISCUSSION
The anti-fluorescein antibody used in this study (4-4-20)
has already been extensively characterized. Spectro-
scopic and binding characteristics (Bates et al., 1985),
primary structure (Bedzyk et al., 1989), and three-di-
mensional crystal structure with fluorescein in the bind-
ing site (Gibson et al., 1988; Herron et al., 1989) are
known. Binding of fluorescein in the antibody's active
site is reported to both shift the wavelength ofmaximum
absorbance of fluorescein from 493 to 506 nm and
quench a maximum of 96.4% of the fluorescence emis-
sion of the hapten (Kranz et al., 1982).
With this information already available, it was appro-
priate to quantitate binding of fluorescent hapten not in
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isotropic solution but as membrane-bound antigen
where the architecture of various lipids as well as the
differences in the interfacial physical nature ofthree dif-
ferent biomembrane models could affect the presenta-
tion of covalently-bound fluorescein to solution-phase
antibody. Fluorescence methods for observing these reac-
tions in lipid monolayers, micelles, and vesicles were
thus used to quantitate surface recognition.
Among the different methods used, binding is directly
visualized using fluorescence microscopy to observe fluo-
rescence quenching of DODA-(EO)4-FITC and cluster-
ing of this quenched fluorescein-lipid bound to the anti-
body into dark domains surrounded by homogeneous
fluorescence (Fig. 7). The formation of those domains
originates in the binding of the antibody to DODA-
(EO)4-FITC followed by the diffusion of this lipid-pro-
tein complex in the plane of the monolayer with subse-
quent formation of two-dimensional protein domains.
Specific binding is necessary to anchor the proteins and
thus compels all bound protein to assume similar orienta-
tions in two dimensions, promoting formation oftwo-di-
mensional domains through surface diffusion ofthe indi-
vidual lipid-protein complexes. Thus, the conclusion
that specific binding takes place is supported both by the
formation of dark lipid clusters (quenching of fluores-
cein-lipid fluorescence) and the presence ofthe antibody
in the same clusters as evidenced by the fluorescence of
the XRITC-labeled antibody (Fig. 7). Possible phase sep-
aration of DODA-(EO)4-FITC has been ruled out both
by measuring its miscibility with POPC in monolayers
and by observing the behavior of this lipid film mixture
upon compression in absence of antibody by fluores-
cence microscopy. Indeed, high miscibility ofPOPC and
DODA-(EO)4-FITC has been shown by measuring sur-
face pressure isotherms of mixtures of these compounds
at several molar ratios. An increase of the surface pres-
sure of DODA-(EO)4-FITC phase transition as a func-
tion ofPOPC molar ratio was observed. This criteria has
been shown to indicate high miscibility of the com-
pounds (Cadenhead, 1985). Moreover, by fluorescence
microscopy, a homogeneous bright microscope field
without dark domains has been observed for POPC and
DODA-(EO)4-FITC mixtures. Both methods have thus
shown that these compounds are highly miscible (un-
published results).
It is highly probable that POPC molecules are also
included in those dark domains as a mixture with
DODA-(EO)4-FITC since the molecular area of each
bound individual antibody (-7,000 A2/molecule; Uz-
giris and Kornberg, 1983) is much larger than that of
DODA-(EO)4-FITC (- 130 A2/molecule at 12 mN/m;
unpublished results). Thus, in any given protein domain,
the molecular area of each bound antibody can be ac-
commodated by at least one bound DODA-(EO)4-FITC
molecule (considering partial saturation ofthe antibody)
and approximately 100 POPC molecules (67 A2/mole-
cule; unpublished results). It is uncertain whether the
original 1 mol% DODA-(EO)4-FITC ratio in the POPC
matrix is conserved within the lipid clusters but, obvi-
ously, there is enough room to accomodate such a lipid
mixture.
Such protein domains have already been observed by
fluorescence microscopy in the case of streptavidin
bound specifically to biotin lipid monolayers (Blanken-
burg et al., 1989) and those have been shown to be crys-
talline (Ahlers et al., 1989; Darst et al., 1991). Moreover,
using a very similar system, Uzgiris and Kornberg (1983)
have found that monoclonal anti-dinitrophenyl antibod-
ies formed two-dimensional crystals upon specific bind-
ing to DNP-PE monolayers. The protein domains ob-
served in the present study may also be crystalline but
electron diffraction measurements are necessary to as-
sess this question. Even though the high resolution three
dimensional structure of the Fab fragment of this anti-
body is already known (Herron et al., 1989), further de-
tailed structural electron diffraction measurements
might provide new information with regard to relative
antibody-membrane positional and spatial determinants
and the disposition of antibody Fab and Fc fragments in
both bound and unbound states.
Quantitative binding monitored by fluorescence
quenching measurements of the different fluorescein-li-
pids both in emulphogene micelles and monolayers
show surprisingly the same trend and nearly the same
relative quenching differences between lipids. These two
model membrane systems have very different properties.
The orientation of the compounds, the lateral pressure
in both systems, and their respective diffusion or ex-
change rates are very different. The micellar system has
an extremely mobile surface due to the rapid exchange of
the detergent molecules between the different micelles.
This fact increases the probabilities that the antibody
could bind all hapten-containing molecules present in
this dynamic milieu. It can thus be hypothesized that the
organization of the monolayer film does not hinder
complete binding between the fluorescein-lipids and the
antibody since lipids show similar fluorescence quench-
ing both in monolayers and emulphogene micelles and
more qualitatively in giant vesicles.
The primary question becomes, "what is the basis for
different degrees of antibody recognition and fluores-
cence quenching seen in the various lipids in the three
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FIGURE 8 Phase contrast (A, D, G, J), fluorescein filter (B, E, H, K), and sulforhodamine filter (C, F, I, L) micrographs of XRITC-labeled
anti-fluorescein antibody binding to giant vesicles ofeither 1 mol% DODA-(EO)4-FITC (A, B, C), DPPE-FITC (D, E, F), Egg PE-FITC (G, H, I) in
99 mol% DPPC, or pure DPPC vesicles (J, K, L). Flow cell and conditions are detailed in text. Scale bar = 30 qm.
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0 their ability to bind and quench fluorescein (Bates et al.,
(A) Free Fluoresceln 198$5). Interestingly enough, widely different degrees of
quenching and binding constants were found, despite
] j 111\ d l | high amino-acid sequence homologies (most amino-acid
, AREhll l differences are found on the third hypervariable loop).co
However, all sister antibodies to the 4-4-20 prototype
show lower quenching efficiencies and have a histidine
-20 4 l l u | residue on the light chain (position 39), whereas 4-4-20
l antibody has an arginine residue at the 39th position
UJ (ARG 39L) instead. Crystallographic analysis (Herron et
al., 1989; Gibson et al., 1988) of the Fab fragment of
-30 - . . . 4-4-20 antibody has recently shown that formation ofan
10 20 30 40 50 enol-arginine ion pair between enolic group on fluores-
cein xanthoyl ring and ARG 39L in low dielectric me-
0 dium deep in the binding pocket of the antibody may
(B) DODA-(EO)4-FITC account for the 2-3 orders ofmagnitude increase in bind-
ing affinity of the 4-4-20 molecule relative to the other
E members of the idiotypic anti-fluorescein family. Not
c only is ARG 39L critical for high affinity binding, but its
0 41VItlll t l ] |§ 1 1 )1 | 11 | | position deep in the interior ofthe protein in an environ-
ment of low dielectric constant ensures that fluorescein
m
-20 must penetrate deep into the active site to be fully
CU @ r | ~~~~~~~~~~~bound.Although unelucidated, this interaction may be
LU critical to the higher degrees of quenching seen also for
4-4-20 antibody compared with the other sister bodies.
-30 - . i*i . With ARG 39L present, 4-4-20 antibodies quench up to
0 10 20 30 40 50 96.4% of fluorescence emission. Antibodies having histi-
dine 39 substituted here show less than 60% quenching.
(C) DPPE-FITC
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FIGURE 9 Molecular dynamics simulations results monitoring the
electrostatic energy between ARG39L in the antibody binding site and
fluorescein over the duration of a 48-picosecond molecular dynamics
run. See text for further details ofmolecular dynamics model: (A) anti-
fluorescein antibody Fv fragment bound to free fluorescein, (B) anti-
fluorescein antibody Fv fragment bound to DODA-(EO)4-FITC lipid
at a lipid monolayer interface, (C) anti-fluorescein antibody Fv frag- 30
ment bound to DPPE-FITC lipid at a lipid monolayer interface. See 0 10 20 30 40 50
Fig. 1 for model geometry.
Time (picosec.)
model membrane systems?". While differing lipid struc- FIGURE 10 Fluctuations in the angle defined by intersecting planes
tures appear to be integrally involved in the answer, jus- containing the Ca backbone ,3-sheet structure ofthe antibody variable
tification is not straightforward. Five different prototype heavy (VH) and variable light (VL) chain domains as a function of
antifluorescyl antibodies have been characterized in
fluorescein binding in the various models. See Fig. 2.
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We therefore turned to computational techniques to
assist in our experimental interpretations as well as in
designing new experiments. One goal is to distinguish
antibody binding or partial binding from fluorescence
quenching (attributed only to full binding). Evidence
from others (Herron et al., 1989; Berlman, 1970) sup-
ports three probable quenching mechanisms of fluores-
cein in the antibody binding cleft: (a) ring stacking be-
tween various aromatic amino acid residues lining the
binding site and fluorescein, (b) changes in the intramo-
lecular angle defined by the plane of fluorescein's xan-
thenone ring and the plane of its phenylcarboxy ring,
and (c) delocalization of ir electrons on fluorescein's xan-
thenone ring by ionic complexation between fluorescein
enolate moieties and histidine and/or arginine residues
in the binding site. By contrast, fluorescein binding is
thermodynamically driven and may be independent of
any electronic quenching events between fluorescein
and the antibody binding site, particularly if binding is
not complete or compromised by hapten structure
(Swindelhurst and Voss, 1991).
Our MD data demonstrate that ring stacking is great-
est in the model containing free fluorescein. The angular
data (not shown) evidences more quenching interactions
(possible fluorescein alignment with TYR37L and TRP
33H, and ring stacking) for free fluorescein than for
DPPE-FITC and DODA-(EO)4-FITC. Reduced binding
site fluctuations indicated from both distance-time and
VH- VL plane angle data could lead to reduced ring stack-
ing in constrained systems like DPPE-FITC. Overall, the
binding site for free fluorescein remains larger than that
for either lipid as defined by different combinations of
distances and angles for this binding site geometry. This
supports both the experimental evidence on extents of
quenching as well as our contention that lipid-bound
haptens rigidify the binding site. That this results in re-
duced binding is addressed below. Additionally, intramo-
lecular ring angles between phenyl and xanthenone fluo-
rescein components remain similar in all three cases of
simulated fluorescein binding, despite differences in
spacer architecture of the lipids. This indicates, at least
on the MD scale, that contributions from this quenching
mechanism are identical in all cases and cannot distin-
guish our experiments. Charge-charge interactions be-
tween fluorescein's enolate and ARG39L are most favor-
able for DPPE-FITC, but both binding site and fluores-
cein mobility become highly damped in this case,
yielding negative entropic contributions which might
not be realistic as they result in structural changes in the
Fv in this case (Fig. 10 and unpublished data).
The fact that both the distance and energy values as
well as the angle between the two ring components of
fluorescein are approximately equal for all three types of
fluorescein haptens leads us to believe that the quench-
ing mechanism is similar in these different systems with
the possible exception of various modes of ring stacking.
Hapten binding then becomes the primary determinant
for different extents of quenching. The much reduced
quenching in DPPE-FITC and somewhat reduced
quenching in DODA-FITC lipids could then be due sim-
ply to reduced binding capabilities, and not from differ-
ent quenching mechanisms. In fact, fluorescence inten-
sity from micellar solutions of each hapten at very simi-
lar concentrations are in close agreement, indicating that
quantum yields are very comparable in all systems. As-
suming identical quenching mechanisms, binding and
not quenching gives different quenching yields in each
case. This leads to the question ofbinding site adaptabil-
ity which we have addressed through structural fluctua-
tions and mobility.
We set up the MD runs with the fully bound lipid-anti-
body state. The question in the simulation is how the
binding site changes after some molecular dynamics.
Since our results show that the average values of each
parameter mentioned above are similar but the degree of
fluctuation is different, the conclusion from the simula-
tions is that the reduced quenching of DPPE (and
DODA-FITC to an extent) is due to reduced binding,
which in turn is due to loss of binding site mobility, con-
figurational freedom, and entropy upon full binding.
Damping of motional freedom within the binding site
causes conformational changes not only in the binding
site itself but also in the quaternary structure ofthe anti-
body (Fig. 10). In order for binding to occur, entropic
losses from binding must be overcome. Loss ofoptimum
binding conformation in turn induces increases in en-
thalpy. Support for this comes from previous thermody-
namic studies (Herron et al., 1986) which showed nega-
tive heat capacities attributed largely to hydrophobic ef-
fects of hapten binding in 4-4-20 antibody for free
fluorescein. Negative entropic contributions observed in
these studies were attributed to restrained vibrational
contributions and conformational changes upon hapten
binding.
This leads us to believe that the 70% quenching seen in
experiments with the DODA lipid might be further in-
creased if the spacer length is increased. It appears that
fluorescein and the binding pocket must both be allowed
to move freely to achieve maximum quenching. When
fluorescein binds, it must allow a certain amount ofmo-
bility for itself and for the interacting amino acid resi-
dues in the binding site. Otherwise, the rigid binding site
cannot accommodate or maintain stable ligand binding.
This rationale may also be extended to explain why egg-
PE shows so little quenching.
When considering lipid architecture, it appears essen-
tial that the covalently conjugated fluorescein hapten be
able to penetrate the binding site sufficiently close to
ARG39L to form a salt bridge with an enolic oxygen of
fluorescein's xanthene ring. Insufficient penetration
would result in only partial or even no complex forma-
tion, decreased binding affinity, and partial or no
quenching. The van der Waals contact distance from
position 5 (isothiocyanate position) ofthe benzoyl group
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of fluorescein bound in the active site to the tyrosine 103
amino acid residue positioned outermost on the tip of
the Fab binding site is 6.00 A. Considering another van
der Waals contact distance of 3.5 A as the minimum
approach distance between the tyrosine and a lipid head
group exterior to the binding site, a minimum of 10 A,
and more likely 15 A is needed as a spacer length to allow
an immobilized, covalently attached fluorescein hapten
full ability to enter the antibody active site.
The only lipid able to fulfill this requirement experi-
mentally is DODA-(EO)4-FITC. The long, hydrophilic
spacer connecting fluorescein to the hydrophobic tail re-
gion of the lipid has an approximate length of 23.3 A,
based on an energy-minimized CPK model. DPPE-
FITC and Egg PE-FITC are clearly lacking a spacer, as
the length from the isothiocyanate of fluorescein to the
phosphodiester group along the ethanolamine chain
amounts to only a fraction of the needed length (6.9 A).
Moreover, a ring of positive charge surrounding the
mouth ofthe antibody binding site (Herron et al., 1989)
would tend to hinder the phosphodiester delocalized an-
ion of DPPE-FITC and Egg PE-FHTC from penetrating
into the antibody active site. Indeed, the MD evidence
presented here clearly show the hindered approach ofthe
Fv fragment to bind DPPE-FITC at the monolayer inter-
face, as well as the dramatic conformational relaxation
required to accommodate such binding. Fig. 11 shows
the differences in the approaches by the Fv 4-4-20 frag-
ment to the monolayer models containing either of the
fluoresceinated lipids, DODA-(EO)4-FITC (Fig. A)
and DPPE-FITC (Fig. 11 B). It is readily apparent that
DODA's long spacer (Fig. A) allows an easy approach
of the antibody to bind the fluorescein hapten without
any steric interference from the monolayer interface.
Connolly surface models including the antibody hydra-
tion shell (not shown) demonstrate that the long spacer
of the DODA system alleviates any need for a close ap-
proach that would hinder full binding of fluorescein
deep into the active site, thus permitting full quenching.
Alternatively, DPPE-FITC (Fig. 11 B) presents the fluo-
rescein hapten so close to the interface that, in order to
gain full binding for quenching, the Fv fragment must
actually penetrate the monolayer. This steric effect must
cause conformational changes in the protein (as shown
in Fig. 10) and disrupt monolayer packing. Electrostatic
interactions from a positive protein charge around the
binding site mouth and the negative phosphodiester
head group on the lipids may also contribute unfavor-
able energetic factors to this process of recognition by
preventing a full binding of the hapten deep into the
binding cleft. Thus, less fluorescein in this system is
quenched experimentally.
Although the spacer effect is critical, our data demon-
strate that hapten presentation is affected by factors in
the lipid acyl region. Petrossian and Owicki (1984) have
also shown that Egg PE-FITC does not bind to the anti-
fluorescein antibody in small unilamellar vesicles. Their
monolayer
igment
old
5 monolayer
Fv fragment
FIGURE 11 Comparisons of the Fv fragment crystal structure of the
anti-fluorescein antibody fully bound to fluorescein-lipids, and energy-
minimized in the molecular dynamics monolayer model. Perspective is
identical in both pictures, but the scale has been changed to fill the
screen with each image: (A) Fv-DODA(EO)4-FITC complex at the
model lipid monolayer interface, and (B) Fv-DPPE-FITC complex at
the model lipid monolayer interface.
data, however, was explained by the absence of a long
enough spacer between fluorescein in the head group
and the fatty acid chains. The present data shows that
this simple interpretation cannot account for quenching
differences between these. Indeed, DPPE-FITC, which
bears the same polar head group as Egg PE-FITC, shows
a significant fluorescence quenching by the antibody in
micelles, monolayers and giant vesicles. Therefore, an-
other mechanism must be put forward to explain this
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difference between the behavior ofthese two fluorescein-
lipids.
Time-resolved computer modeling data based on
dioleoylphosphatidylcholine indicate that unsaturated
alkyl chains in phospholipids can, over very short time
scales, cause phosphatidylcholine head groups to par-
tially rescind into a loop formed by kinked and curled
unsaturated alkyl chains (figure not shown). In mixed
monolayers and vesicles, this could result in the fluores-
cein hapten being pulled away from the aqueous environ-
ment, up against the hydration shell of the aggregated
lipid membrane and out ofreach ofthe antibody. Such a
conformation reduces the effective spacer length be-
tween the membrane and the hapten, virtually prevent-
ing the antibody from any binding at all. This explana-
tion, however, does not apply to micelle systems where
surfactant exchange is so rapid and aggregate surfaces are
always in rapid dynamic flux. The oleoyl acyl chains
must affect head group conformation and hapten presen-
tation.
Our conclusion is, therefore, that antibody recogni-
tion, binding, and fluorescence quenching in these three
model membrane systems are much more dependent on
lipid architecture, in particular, the requirement of a
long spacer to attach the fluorescein hapten, than on the
physical structure of the biomembrane models in which
the hapten is presented. However, the behavior of the
bound protein depends on the physical properties ofthe
model membrane, as shown in Fig. 6 where the mobility
of the antibody-lipid complex is determined by the lat-
eral packing within the monolayer. Fluorescence
quenching, as a direct indicator of recognition, requires
fluorescein to sit deep in the antibody binding site, com-
plexed in a salt bridge with ARG 39L at the base of the
binding pocket. Only spacer-containing lipids allowing
the fluorescein moiety a 10-15 A distance to enter the
pocket will manifest full binding affinity and maximum
quenching efficiency. In this respect, only DODA-(EO)4-
FITC fulfills these criteria.
Experimentally, these modeling predictions are con-
firmed, with the antibody able to recognize 70% of this
lipid-bound hapten in monolayers, micelles, and vesi-
cles. By contrast, 50% ofDPPE-FHTC could be quenched
in these systems indicating some partial binding and in-
complete hapten penetration. Egg PE-FITC, however,
showed less than 10% quenching in monolayers, mi-
celles, and vesicles, indicating a lipid conformation and
hapten presentation completely incompatible with anti-
body recognition and binding. Identical head group
chemistries in these two lipids prevent simple interpreta-
tion based on short spacer haptens. Acyl chain satura-
tion affects hapten presentation at the membrane-water
interface. Additional computational analyses calculating
energy fluctuations and contributions to binding capaci-
ties by ring residues in the 4-4-20 active site are currently
underway to clarify these differences. Partial binding of
fluorescein haptens in the binding cleft is also being simu-
lated to assess incomplete quenching and contributions
from residues in the active site to accommodate full
binding.
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